Evidence map›Paper›PMID 36416976›Full record

ReviewArchives of dermatological research2023

Staged melanoma excision requires larger margins for tumor clearance and results in low rates of recurrence.

Jaclyn Rosenthal Himeles, Maressa C Criscito, Nayoung Lee, Mary L Stevenson, John A Carucci

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of dermatological research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jaclyn Rosenthal HimelesThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, 222 East 41st Street, New York, NY, 10016, USA.
Maressa C CriscitoThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, 222 East 41st Street, New York, NY, 10016, USA.
Nayoung LeeThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, 222 East 41st Street, New York, NY, 10016, USA.
Mary L StevensonThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, 222 East 41st Street, New York, NY, 10016, USA.
John A CarucciThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, 222 East 41st Street, New York, NY, 10016, USA. john.carucci@nyulangone.org.
New York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is controversy regarding the optimal surgical modality and ideal recommended margins for treating melanoma in situ (MIS) and invasive melanoma (IM). Although wide local excision is recommended, staged excision offers excellent margin control and low recurrence rates. In this manuscript, we reviewed a 10-year experience of staged excisions for the treatment of MIS and IM. A retrospective review was performed of 130 MIS and 32 IM cases treated with staged excision from April 2012 to April 2022. Staged excision was performed on the head and neck in 102 (79%) MIS and 23 (72%) IM cases. Approximately 10% of cases required surgical margins above the current recommendations (11 (9%) MIS and 6 (19%) IM). Twenty-three (19%) MIS and 7 (22%) IM cases required more than one excision to obtain clearance. Recurrence rates among MIS and IM were 0.0% and 0.6%, respectively. Upstaging occurred in 5 (4%) MIS and 7 (22%) IM cases. Complex repairs were performed on 82 (63%) MIS and 17 (53%) IM cases. Our findings revealed that staged excision provides effective margin control and low recurrence rates. Approximately 10% of patients required margins greater than the current recommendations, leading to larger defects and more complex repairs.

Indexed as

MelanomaSkin NeoplasmsCutaneous Malignant MelanomaHumansMargins of ExcisionNeoplasm Recurrence, LocalRetrospective StudiesInvasive melanomaMelanoma in situStaged excisionTreatment

Identifiers

PMID36416976
OpenAlexW4309700675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.